<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0304221906
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2007
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CERNEVIT
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MULTIVITAMINS
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder for solution for injection/infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        215.30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="FAREVA PAU 1" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            FAREVA PAU 1
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 416]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Arabian Health Care Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            BAXTER
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A11BA
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>CERNEVIT is a powder for solution for injection or infusion. It contains 12 vitamins (see Section 6).</p><p>CERNEVIT is used to give your daily requirement of multi-vitamins straight into your blood. It is used when you cannot take enough food by your mouth. It is usually given with other things such as nutrition solutions and minerals.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>You will NOT be given CERNEVIT if: </strong></p><ul><li>you are allergic (hypersensitive) to the active substance or any of the ingredients of this medicine, especially vitamin B1 or soy protein or peanut protein (see Section 6, Contents of the pack and other information),</li></ul><p>&nbsp;</p><ul><li>you have too much of one of the vitamins in CERNEVIT stored in your body (called &#39;hypervitaminosis&#39;).</li></ul><p>&nbsp;</p><p>Do not have CERNEVIT if any of the above apply to you. If you are not sure talk to your doctor, nurse or pharmacist.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor, pharmacist or nurse before you are given CERNEVIT if:</p><ul><li>you are having vitamin A (retinol) from other sources</li></ul><p>&nbsp;</p><ul><li>you have kidney problems. In this case your doctor will carefully monitor your fat-soluble vitamin levels. The fat-soluble vitamins are A, D, E and K.</li></ul><p>&nbsp;</p><ul><li>you have liver disease. Your doctor will do blood tests to check how well your liver is working. They will monitor the levels of certain &#39;enzymes&#39; in your liver.</li></ul><p>&nbsp;</p><p>If you are not sure if any of the above apply to you, talk to your doctor, nurse or pharmacist before being given CERNEVIT.</p><p><strong>&nbsp;</strong></p><p><strong>Your doctor will make sure that:</strong></p><ul><li>you are given additional vitamin K if you need it. CERNEVIT does not contain vitamin K.</li></ul><p>&nbsp;</p><ul><li>your body has all that it needs for good health. If necessary, you may also be given minerals, amino acids (the building blocks of protein), fatty acids (the building blocks of fats), electrolytes (salts) and sugar solutions (such as glucose).</li></ul><p>&nbsp;</p><p><strong>Other medicines and CERNEVIT </strong></p><p>Please tell you doctor, nurse or pharmacist if you are taking or have recently taken any other medicines. This includes medicines obtained without a prescription, including herbal medicines.</p><p>This is because some of the ingredients in CERNEVIT can affect the way some medicines work.</p><p>&nbsp;</p><p>In particular tell your doctor, nurse or pharmacist if you are taking any of the following medicines:</p><ul><li>levodopa (a medicine used for Parkinson&#39;s disease). The vitamin B<sub>6</sub> (pyridoxine) in CERNEVIT can affect this medicine</li><li>Phenobarbital, phenytoin and/or primidone (used in epilepsy for fits or convulsions and sometimes other conditions). The folic acid in CERNEVIT may interact with these medicines.</li></ul><p>Your doctor may monitor the levels of these medicines in your blood and may have to adjust their dose when you start or stop taking CERNEVIT.</p><p>&nbsp;</p><p><strong>Tests while you are having CERNEVIT</strong></p><p>CERNEVIT contains 69 &mu;g biotin per vial (5 mL). If you are about to undergo laboratory testing you must tell your doctor or the laboratory personnel that you are taking or have recently taken CERNEVIT, because biotin may affect results of such tests. Depending on the test, the results may be falsely elevated or falsely low due to biotin. Your doctor may ask you to stop taking CERNEVIT before performing laboratory tests. You should also be aware that other products that you may take, such as multivitamins or supplements for hair, skin, and nails could also contain biotin and affect the results of laboratory tests. Please inform your doctor or the laboratory personnel, if you are taking such products.</p><p>&nbsp;</p><p>If you are due to have a urine or a blood test, tell your doctor you are having CERNEVIT:</p><ul><li>Ascorbic acid may interfere with urine and blood glucose testing systems.</li><li>The folic acid in CERNEVIT may stop the detection of a problem called &lsquo;pernicious anaemia&rsquo;. This is when you have a drop in red blood cells because your body cannot properly absorb vitamin B<sub>12</sub> from your gut.</li></ul><p>&nbsp;</p><p><strong>Important Information about some of the ingredients of CERNEVIT </strong></p><p>CERNEVIT contains 24 mg sodium (1 mmol) per vial. This should be taken into consideration by patients on a controlled sodium diet.</p><p><strong>Fertility, pregnancy and breast-feeding </strong></p><p>If you are pregnant or breast-feeding, think you might be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p>&nbsp;</p><p><em>Pregnancy</em></p><p>You may receive CERNEVIT during pregnancy if required, providing the indication and dosages are observed to avoid vitamin overdose.</p><p>&nbsp;</p><p><em>Breast-feeding</em></p><p>The use of CERNEVIT is not recommended if you are breast-feeding. If you breast-feed whilst taking CERNEVIT there is a danger that your baby could get an overdose of vitamin A.</p><p>&nbsp;</p><p><em>Fertility</em></p><p>No data are available on the effect of CERNEVIT on male or female fertility</p><p>&nbsp;</p><p><strong>Effects on ability to drive and use machines</strong></p><p>There is no information on the effects of CERNEVIT on the ability to operate an automobile or other heavy machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>CERNEVIT will be given to you by a doctor or nurse.</p><p>&nbsp;</p><p><strong>How CERNEVIT is given</strong></p><ul><li>The CERNEVIT powder will first be dissolved with a liquid such as &#39;sterile water for injection&#39;. This will be mixed with a larger volume of fluid before it is given to you.</li></ul><p>&nbsp;</p><ul><li>It will be given into a vein as a drip (slow intravenous infusion) over at least ten minutes.</li></ul><p>&nbsp;</p><ul><li>CERNEVIT can also be added to other nutrition solutions. This mixed nutrition solution will be given to you as a drip into your vein.</li></ul><p><strong>&nbsp;</strong></p><p><strong>The recommended dose</strong></p><p>Your doctor will decide how much CERNEVIT you should be given. The amount you will be given depends upon your age, weight and the reason you are being given the medicine.</p><p>&nbsp;</p><ul><li><strong>Adults and children over 11 years</strong>: the recommended dose is one vial (small glass bottle) of CERNEVIT each day.</li></ul><p>&nbsp;</p><ul><li><strong>Children under 11 years</strong>: not recommended.</li></ul><p>&nbsp;</p><p><strong>If you are given too much </strong></p><p>Your doctor or nurse will give you CERNEVIT so it is unlikely you will be given too much. If you are worried that you have had too much, tell your doctor or nurse.</p><p>&nbsp;</p><p>Signs of overdose of CERNEVIT are mostly the signs of overdose of vitamin A:</p><ul><li>Signs of sudden overdose of vitamin A include:</li></ul><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; gastrointestinal disorders (nausea, vomiting),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervous system disorders (headache, swelling of the optic nerve, convulsions) due to an increased pressure in your head,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; psychiatric disorders (irritability),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin disorders (delayed peeling of the skin).</p><p>&nbsp;</p><ul><li>Signs of long-term overdose of vitamin A include:</li></ul><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache due to an increased pressure in your head,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bone disorders (tender or painful swellings at the ends of your limbs).</p><p>&nbsp;</p><p>If you notice any of these signs of overdose, tell your doctor or nurse. They may stop your CERNEVIT infusion.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine.</p><p>&nbsp;</p><p>The following side effect is common and could affect 1 to 10 users in 100:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain at the site of injection</p><p>&nbsp;</p><p>The following side effect are uncommon and could affect 1 to 10 users in 1,000:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling sick (nausea),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; being sick (vomiting)</p><p>&nbsp;</p><p>The following side effect have been reported at an unknown frequency:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic reactions, with respiratory difficulties, chest pain, tightening of the throat, urticaria, rash, skin redness, abdominal discomfort, as well as cardiac arrest</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased levels of vitamin A and vitamin A carrier protein in blood</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taste alteration (metallic taste)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accelerated heart rate</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accelerated breathing rate</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhoea</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in level of liver enzymes and bile acid</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pruritus (itching)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever, generalized soreness, reactions at the site of infusion such as burning sensation, rash.</p><p>&nbsp;</p><p>If you show any symptom of an allergic reaction such as respiratory difficulties, chest pain, tightening of the throat, urticaria, rash, skin redness, abdominal discomfort, inform a doctor or nurse immediately. They will stop the infusion and conduct the necessary emergency measures.</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your&nbsp; doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system (see details below). By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p>&nbsp;</p><ul><li><strong>Saudi Arabia:</strong></li></ul><table border="1" cellspacing="0" cellpadding="0" style="width:642px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>- SFDA Call Center: 19999</p><p>- E-mail: npc.drug@sfda.gov.sa</p><p>- Website: https://ade.sfda.gov.sa/ <u>&nbsp;</u>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:642px"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Because CERNEVIT is usually given in hospital it will be stored safely and correctly by the hospital staff. If you do need the storage conditions they are given below.</p><ul><li>Keep this medicine out of the sight and reach of children.</li><li>This &nbsp;medicine will not be used after the expiry date that is stated on the label after &#39;EXP&#39;. The expiry date refers to the last day of that month.</li><li>Do not store above 25&deg;C.</li><li>Store in the outer carton in order to protect from light.</li><li>CERNEVIT should not be used if the solution is not clear, or if the vial is damaged in any way.</li><li>Once CERNEVIT has been mixed with water it should not be kept for more than 24 hours at 2 to 8 &deg;C, unless otherwise specified by your doctor.</li><li>Partly used vials should not be used again. Any left-over CERNEVIT should be thrown away safely by a healthcare professional.</li><li>All equipment used will be disposed of safely by a healthcare professional after use.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What CERNEVIT contains</strong></p><ul><li>The active substances per vial are:</li></ul><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; retinol palmitas (vitamin A) 3500 UI,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; colecalciferol (vitamin D<sub>3</sub>) 220 UI,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DL-&alpha;-tocopherol (vitamin E) 10.20 mg,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ascorbic acid (vitamin C) 125 mg,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cocarboxylase tetrahydrate (vitamin B<sub>1</sub>) 5.80 mg,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; riboflavin sodium phosphate dehydrate (vitamin B<sub>2</sub>) 5.67 mg,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pyridoxine hydrochloride (vitamin B<sub>6</sub>) 5.50 mg,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cyanocobalamin (vitamin B<sub>12</sub>) 6 &micro;g,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; folic acid 414 &micro;g,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dexpanthenol 16.15 mg,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; D-Biotin 69 &micro;g,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nicotinamide (vitamin PP) 46 mg.</p><p>&nbsp;</p><p>IU = International Units</p><p>mg = milligrams</p><p>&mu;g = micrograms</p><p>&nbsp;</p><ul><li>The other ingredients are:</li></ul><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; glycine,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; glycocholic acid,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; soybean phosphatides.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It may also contain small amounts of sodium hydroxide or hydrochloric acid for pH adjustment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                	What CERNEVIT looks like and the contents of the pack
	CERNEVIT is a powder for solution for injection or infusion. It is an orange-yellow cake of powder supplied in brown glass vials. It is packaged in cartons containing 1, 10 or 20 vials.
	
	Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Baxter S.A.</strong></p><p>Boulevard Rene Branquart 80</p><p>7860 Lessines</p><p>Belgium</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in March 2019.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">سيرنيفيت هو مسحوق للإذابة في محلول الحقن أو التسريب الوريدي. وهو يحتوي على 12 فيتامين (انظر القسم 6).</p><p>يُستعمل سيرنيفيت لإعطائك احتياجاتك اليومية من الفيتامينات المتعددة في الدم مباشرةً. وهو يُستعمل في الحالات التي يتعذر فيها تناول كميات كافية من الطعام عن طريق الفم. ويتم إعطاؤه عادةً بصحبة أدوية أخرى مثل محاليل التغذية والمعادن.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لن يتم إعطاؤك سيرنيفيت في الحالات التالية:</strong></p><ul><li dir="RTL">&nbsp;إذا كنت تعاني من حساسية (فرط تحسس) للمادة الفعالة أو لأيٍّ من مكونات هذا الدواء، وخاصةً فيتامين &quot;ب1&quot; أو بروتين الصويا أو بروتين الفول السوداني (انظر القسم 6، محتويات العبوة ومعلومات أخرى)، و</li></ul><p>&nbsp;</p><ul><li dir="RTL">&nbsp;إذا كان جسمك يحتوي على كمية كبيرة للغاية من أحد الفيتامينات الموجودة في سيرنيفيت (حالة تُسمى &quot;فرط الفيتامين&quot;)،</li></ul><p>&nbsp;</p><p dir="RTL">لا تتعاطى سيرنيفيت إذا كانت الموانع السابقة تسري عليك. إذا لم تكن متأكدًا، فاستشر طبيبك أو الممرضة المسؤولة عن رعايتك أو الصيدلي الذي تتعامل معه.</p><p>&nbsp;</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL">استشر طبيبك أو الصيدلي الذي تتعامل معه أو الممرضة المسؤولة عن رعايتك قبل إعطائك سيرنيفيت في الحالات التالية:</p><ul><li dir="RTL">&nbsp;إذا كنت تحصل على فيتامين &quot;أ&quot; (الرتينول) من مصادر أخرى</li></ul><p>&nbsp;</p><ul><li dir="RTL">إذا كانت لديك مشكلات في الكلى. في هذه الحالة، سيتابع طبيبك بدقة مستويات الفيتامينات القابلة للذوبان في الدهون لديك. الفيتامينات القابلة للذوبان في الدهون هي &quot;أ&quot;، و&quot;د&quot;، و&quot;هـ&quot;، و&quot;ك&quot;.</li></ul><p>&nbsp;</p><ul><li dir="RTL">إذا كان لديك مرض في الكبد. سيقوم طبيبك بإجراء تحاليل دم لك لمعرفة كفاءة وظائف الكبد لديك. سيتابع طبيبك مستويات &quot;إنزيمات&quot; معينة في الكبد لديك.</li></ul><p>&nbsp;</p><p dir="RTL">إذا لم تكن متأكدًا مما إذا كانت الحالات السابقة تسري عليك، فاستشر طبيبك أو الممرضة المسؤولة عن رعايتك أو الصيدلي الذي تتعامل معه قبل إعطائك سيرنيفيت.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>سيتأكد طبيبك مما يلي:</strong></p><ul><li dir="RTL">حصولك على جرعات إضافية من فيتامين &quot;ك&quot; إذا كنت بحاجة إليها. لا يحتوي سيرنيفيت على فيتامين &quot;ك&quot;.</li></ul><p>&nbsp;</p><ul><li dir="RTL">حصول جسمك على جميع الاحتياجات المطلوبة لكي يكون بصحة جيدة. قد يتم إعطاؤك أيضًا معادن، وأحماضًا أمينية<br />(وحدات بناء البروتين)، وأحماضًا دهنية (وحدات بناء الدهون)، ومحاليل إلكترولايت (أملاح)، ومحاليل سكريات (مثل الجلوكوز) عند اللزوم.</li></ul><p>&nbsp;</p><p dir="RTL"><strong>استعمال الأدوية الأخرى مع سيرنيفيت</strong></p><p dir="RTL">&nbsp;يرجى إبلاغ طبيبك، أو الممرضة المسؤولة عن رعايتك، أو الصيدلي الذي تتعامل معه إذا كنت تتناول أو تناولت مؤخرًا أي أدوية أخرى. يشمل ذلك الأدوية التي يتم الحصول عليها دون روشتة طبية، بما في ذلك أدوية الأعشاب.</p><p dir="RTL">وذلك بسبب أن بعض المكونات الموجودة في سيرنيفيت قد تؤثر على طريقة عمل بعض الأدوية.</p><p>&nbsp;</p><p dir="RTL">أبلغ طبيبك، أو الممرضة المسؤولة عن رعايتك، أو الصيدلي الذي تتعامل معه على وجه الخصوص إذا كنت تتناول أيًا من الأدوية التالية:</p><ul><li dir="RTL">ليفودوبا (دواء يُستعمل لعلاج مرض الشلل الرعاش). قد يؤثر فيتامين &quot;ب<sub>6</sub>&quot; (البيريدوكسين) الموجود في سيرنيفيت على<br />هذا الدواء</li><li dir="RTL">فينوباربيتال، و/أو فينيتوين، و/أو بريميدون (أدوية تُستعمل لعلاج نوبات أو تشنجات الصرع وأمراض أخرى في بعض الأحيان). قد يتفاعل حمض الفوليك الموجود في سيرنيفيت مع هذه الأدوية.</li></ul><p dir="RTL">قد يتابع طبيبك مستويات هذه الأدوية في الدم لديك وقد يلجأ لتعديل جرعاتها عند بدء تعاطي سيرنيفيت أو إيقافه.</p><p>&nbsp;</p><p dir="RTL"><strong>إجراء تحاليل أثناء تعاطي سيرنيفيت</strong></p><p dir="RTL">&lrm;تحتوي كل قارورة (5 مل) من سيرنيفيت على 69 ميكروجم من البيوتين. إذا كنت بصدد إجراء تحاليل معملية، يجب عليك إبلاغ طبيبك أو موظفي المعمل أنك تتعاطى أو تعاطيت مؤخرًا سيرنيفيت، وذلك نظرًا لأن البيوتين قد يؤثر على نتائج تلك التحاليل. بحسب طبيعة التحليل، قد يسبب البيوتين الحصول على نتائج خاطئة بالزيادة أو النقصان. قد يطلب منك طبيبك التوقف عن تعاطي سيرنيفيت قبل إجراء تحاليل معملية. تجدر الإشارة أيضًا إلى أن المستحضرات الأخرى التي ربما تتعاطاها مثل الفيتامينات المتعددة أو المكملات الخاصة بالشعر والبشرة والأظافر قد تحتوي هي الأخرى على البيوتين وقد تؤثر على نتائج التحاليل المعملية. يرجى إبلاغ طبيبك أو موظفي المعمل إذا كنت تتعاطى هذه المستحضرات.</p><p>&nbsp;</p><p dir="RTL">&nbsp;إذا كنت بصدد إجراء تحليل بول أو دم، فأبلغ طبيبك أنك تتعاطي سيرنيفيت:</p><ul><li dir="RTL">قد يتداخل حمض الأسكوربيك مع أنظمة تحاليل البول وسكر الدم.</li><li dir="RTL">قد يمنع حمض الفوليك الموجود في سيرنيفيت اكتشاف مشكلة تُعرف باسم &quot;فقر الدم الخبيث&quot;. تحدث تلك المشكلة إذا كان لديك انخفاض في كرات الدم الحمراء بسبب عدم قدرة جسمك على امتصاص فيتامين &quot;ب<sub>12</sub>&quot; بصورة سليمة من أمعائك.</li></ul><p>&nbsp;</p><p dir="RTL"><strong>&nbsp;معلومات مهمة حول بعض مكونات سيرنيفيت</strong></p><p dir="RTL">&nbsp;&lrm;تحتوي كل قارورة من سيرنيفيت على 24 ملجم (1 مللي مول) من الصوديوم. يجب وضع ذلك في الاعتبار بالنسبة للمرضى الذين يتبعون أنظمة غذائية تحتوي على كميات محدودة من الصوديوم.</p><p dir="RTL"><strong>الخصوبة والحمل والرضاعة الطبيعية</strong></p><p dir="RTL">&nbsp;إذا كنتِ حاملاً أو تقومين بالرضاعة الطبيعية أو إذا كنتِ تعتقدين أنكِ ربما تكونين حاملاً أو تنوين الإنجاب، فاستشيري طبيبكِ أو الصيدلي الذي تتعاملين معه قبل تعاطي هذا الدواء.</p><p>&nbsp;</p><p dir="RTL"><em>الحمل</em></p><p dir="RTL">يمكنكِ تعاطي سيرنيفيت أثناء الحمل عند اللزوم، شريطة مراعاة دواعي الاستعمال والجرعات لتلافي تلقي جرعة زائدة من الفيتامينات.</p><p>&nbsp;</p><p dir="RTL"><em>&nbsp;الرضاعة الطبيعية</em></p><p dir="RTL">لا يوصى باستعمال سيرنيفيت إذا كنت تقومين بالرضاعة الطبيعية. إذا قمتِ بالرضاعة الطبيعية أثناء تلقي سيرنيفيت، فسيكون طفلكِ معرضًا لخطر الحصول على جرعة زائدة من فيتامين &quot;أ&quot;.</p><p>&nbsp;</p><p dir="RTL"><em>&nbsp;الخصوبة</em></p><p dir="RTL">لا تتوفر بيانات حول تأثير سيرنيفيت على خصوبة الرجال أو السيدات</p><p>&nbsp;</p><p dir="RTL"><strong>التأثيرات على القدرة على القيادة واستعمال الآلات</strong></p><p dir="RTL">لا تتوفر معلومات حول تأثيرات سيرنيفيت على القدرة على تشغيل السيارات أو الآلات الثقيلة الأخرى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سيقوم طبيب أو ممرضة بإعطاء سيرنيفيت لك.</p><p>&nbsp;</p><p dir="RTL"><strong>كيفية إعطاء سيرنيفيت</strong></p><ul><li dir="RTL">ستتم أولاً إذابة مسحوق سيرنيفيت في سائل مثل &quot;الماء المعقم للحقن&quot;. سيتم خلط هذا المحلول مع كمية أكبر من السائل قبل<br />إعطائه لك.</li></ul><p>&nbsp;</p><ul><li dir="RTL">سيتم إعطاء المحلول في الوريد بطريقة التنقيط (التسريب الوريدي البطيء) لمدة عشر دقائق على الأقل.</li></ul><p>&nbsp;</p><ul><li dir="RTL">يمكن إضافة سيرنيفيت أيضًا إلى محاليل التغذية الأخرى. سيتم إعطاؤك محلول التغذية المخلوط هذا عن طريق التنقيط في الوريد.</li></ul><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>الجرعة الموصى بها</strong></p><p dir="RTL">سيقرر طبيبك مقدار جرعة سيرنيفيت التي يجب إعطاؤها لك. يعتمد مقدار الجرعة المعطاة لك على عمرك ووزنك وسبب إعطائك الدواء.</p><p>&nbsp;</p><ul><li dir="RTL"><strong>البالغون والأطفال الأكبر من 11 عامًا</strong>: الجرعة الموصى بها هي قارورة واحدة (زجاجة صغيرة) من سيرنيفيت كل يوم.</li></ul><p>&nbsp;</p><ul><li dir="RTL"><strong>الأطفال الأصغر من 11 عامًا</strong>: لا يوصى باستعماله.</li></ul><p>&nbsp;</p><p dir="RTL"><strong>في حالة إعطائك جرعة أكبر من اللازم</strong></p><p dir="RTL">&nbsp;سيقوم طبيبك أو الممرضة المسؤولة عن رعايتك بإعطائك سيرنيفيت، ولذا فإن حصولك على جرعة أكبر من اللازم من الدواء هو احتمال مستبعد. إذا كنت قلقًا من حصولك على جرعة أكبر من اللازم، فأبلغ طبيبك أو الممرضة المسؤولة عن رعايتك.</p><p>&nbsp;</p><p dir="RTL">العلامات التي تُنذر بتلقي جرعة زائدة من سيرنيفيت مشابهة في معظمها لعلامات تلقي جرعة زائدة من فيتامين &quot;أ&quot;:</p><ul><li dir="RTL">تشمل العلامات التي تُنذر بجرعة زائدة مفاجئة من فيتامين &quot;أ&quot;:</li></ul><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات في المعدة والأمعاء (غثيان، قيء)، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات في الجهاز العصبي (صداع، تورم العصب البصري، تشنجات) بسبب زيادة الضغط داخل رأسك، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات نفسية (حدة المزاج)، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات جلدية (تقشر متأخر للجلد).</p><p>&nbsp;</p><ul><li dir="RTL">&nbsp;تشمل العلامات التي تُنذر بجرعة زائدة طويلة الأمد من فيتامين &quot;أ&quot;:</li></ul><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع بسبب زيادة الضغط داخل رأسك، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات في العظام (ضعف أو تورمات مؤلمة في نهايات أطرافك).</p><p>&nbsp;</p><p dir="RTL">&nbsp;إذا لاحظت أيًا من هذه العلامات التي تُنذر بتلقي جرعة زائدة، فأبلغ طبيبك أو الممرضة المسؤولة عن رعايتك. قد يقوم الطبيب أو الممرضة بإيقاف تسريب سيرنيفيت عبر الوريد لك.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال مع جميع الأدوية، قد يسبب هذا الدواء حدوث آثار جانبية، بالرغم من أنها لا تحدث لدى جميع المرضى. قد تحدث الآثار الجانبية التالية عند تعاطي هذا الدواء.</p><p>&nbsp;</p><p dir="RTL">الآثار الجانبية التالية شائعة وقد تحدث لدى 1 إلى 10 أشخاص من كل 100 شخص يستعمل هذا الدواء:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في موضع الحقن</p><p>&nbsp;</p><p dir="RTL">&nbsp;الآثار الجانبية التالية غير شائعة وقد تحدث لدى 1 إلى 10 أشخاص من كل 1000 شخص يستعمل هذا الدواء:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; غثيان، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قيء</p><p>&nbsp;</p><p dir="RTL">حدثت الآثار الجانبية التالية لدى المرضى بمعدل تكرار غير معروف:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات تحسسية، مصحوبة بصعوبات في التنفس، وألم في الصدر، واحتقان في الحلق، وشرى، وطفح جلدي، واحمرار في الجلد، وتعب في البطن، بالإضافة إلى السكتة القلبية</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستويات فيتامين &quot;أ&quot; والبروتين الناقل لفيتامين &quot;أ&quot; في الدم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغير في حاسة التذوق (مذاق معدني)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫زيادة سرعة ضربات القلب</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة سرعة معدل التنفس</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع في مستويات إنزيمات الكبد وحمض الصفراء</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة جلدية (هرش)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمى، &rlm;‫ألم في مختلف أنحاء الجسم، تفاعلات في موضع التسريب الوريدي، مثل إحساس بالحرقة، طفح جلدي.</p><p>&nbsp;</p><p dir="RTL">إذا ظهرت عليك أي أعراض تفاعل تحسسي مثل صعوبات في التنفس، أو ألم في الصدر، أو احتقان في الحلق، أو شرى، أو طفح جلدي، أو احمرار في الجلد، أو تعب في البطن، فأبلغ الطبيب أو الممرضة على الفور. سيقوم الطبيب أو الممرضة بإيقاف التسريب الوريدي واتخاذ إجراءات الطوارئ اللازمة.</p><p>&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">إذا شعرت بأي آثار جانبية، فاستشر طبيبك أو الممرضة المسؤولة عن رعايتك أو الصيدلي الذي تتعامل معه. يشمل ذلك أي آثار جانبية محتملة غير واردة في هذه النشرة. &rlm;‫يمكنك أيضًا الإبلاغ عن الآثار الجانبية مباشرةً من خلال نظام البلاغات الوطني (انظر التفاصيل أدناه). من خلال الإبلاغ عن الآثار الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p>&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن أي آثار جانبية</strong>:</p><p>&nbsp;</p><ul><li dir="RTL"><strong>المملكة العربية السعودية</strong>:</li></ul><p>&nbsp;</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:642px"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ والسلامة الدوائية</p><p dir="RTL">- &nbsp;مركز اتصال الهيئة العامة للغذاء والدواء السعودية: 19999</p><p dir="RTL">- &nbsp;البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">- &nbsp;موقع الويب: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p>&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول مجلس التعاون الخليجي الأخرى</strong>:</p><p>&nbsp;</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:642px"><tbody><tr><td><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُرجى الاتصال بالهيئة المختصة ذات الصلة.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">نظرًا لأن دواء سيرنيفيت يتم إعطاؤه عادةً في المستشفى، فسيتولى فريق العمل المختص بالمستشفى حفظه بالطريقة الآمنة والصحيحة. يُرجى الاطلاع على شروط الحفظ المحددة أدناه إذا كنت بحاجة إلى معرفتها.</p><ul><li dir="RTL">يُحفظ هذا الدواء بعيدًا عن مرأى ومتناول الأطفال.</li><li dir="RTL">يحظر استعمال هذا الدواء بعد تاريخ انتهاء الصلاحية المدون على الملصق بعد العبارة &quot;تاريخ الانتهاء&quot;. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</li><li dir="RTL">يحظر حفظ هذا الدواء في درجة حرارة أعلى من 25&deg;م.</li><li dir="RTL">يُحفظ في العبوة الخارجية لمنع تعرضه للضوء.</li><li dir="RTL">يحظر استعمال سيرنيفيت إذا لم يكن المحلول صافيًا، أو في حالة وجود أي تلف بالقارورة.</li><li dir="RTL">بعد خلط سيرنيفيت مع الماء يجب عدم الاحتفاظ به لمدة أكثر من 24 ساعة في درجة حرارة 2 إلى 8 &deg;م، ما لم يحدد طبيبك خلاف ذلك.</li><li dir="RTL">يجب عدم استعمال القوارير مجددًا بعد استهلاك كميات منها. يجب أن يقوم اختصاصي رعاية صحية بالتخلص من أي كميات متبقية من سيرنيفيت بطريقة سليمة وآمنة.</li><li dir="RTL">سيقوم اختصاصي رعاية صحية بالتخلص من جميع الأدوات والأجهزة المستعملة بطريقة سليمة وآمنة بعد الانتهاء من استعمالها.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مكونات سيرنيفيت</strong></p><ul><li dir="RTL">المواد الفعّالة في كل قارورة:</li></ul><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫بالميتات الريتينول (فيتامين &quot;أ&quot;) 3500 وحدة دولية، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كوليكالسيفيرول (فيتامين &quot;د<sub>3</sub>&quot;&rlm;) 220 وحدة دولية، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫دي إل-&rlm;‫ألفا-توكوفيرول (فيتامين &quot;هـ&quot;) 10.20 ملجم، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمض الأسكوربيك (فيتامين &quot;ج&quot;) 125 ملجم، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رباعي هيدرات تميم الكربوكسيلاز (فيتامين &quot;ب<sub>1</sub>&quot;&rlm;) 5.80 ملجم، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فوسفات صوديوم ريبوفلافين لا مائي (فيتامين &quot;ب<sub>2</sub>&quot;&rlm;) 5.67 ملجم، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هيدروكلوريد البيريدوكسين (فيتامين &quot;ب<sub>6</sub>&quot;&rlm;) 5.50 ملجم، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيانوكوبالامين (فيتامين &quot;ب<sub>12</sub>&quot;&rlm;) 6 ميكروجم، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمض الفوليك 414 ميكروجم، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ديكسبانتينول 16.15 ملجم، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫دي-بيوتين 69 ميكروجم، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نيكوتيناميد (فيتامين &quot;بي بي&quot;) 46 ملجم.</p><p>&nbsp;</p><p dir="RTL">وحدة دولية = وحدة بالنظام الدولي</p><p dir="RTL">ملجم = ملليجرام</p><p dir="RTL">ميكروجم = ميكروجرام</p><p>&nbsp;</p><ul><li dir="RTL">المكونات الأخرى:</li></ul><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جلايسين، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمض الجليكوكوليك، و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فوسفاتيدات فول الصويا.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يحتوي أيضًا على كميات صغيرة من هيدروكسيد الصوديوم أو حمض الهيدروكلوريك لضبط درجة الحموضة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>شكل سيرنيفيت ومحتويات العبوة</strong></p><p dir="RTL">سيرنيفيت هو مسحوق للإذابة في محلول الحقن أو التسريب الوريدي. وهو عبارة عن تكتلات مسحوق صفراء مائلة للبرتقالي تأتي في قوارير زجاجية بنية اللون. الدواء معبأ في عبوات تحتوي على 1 أو 10 أو 20 قارورة.</p><p dir="RTL">قد لا يتم تسويق جميع أحجام العبوات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="ltr" style="text-align:left"><strong>Baxter S.A.</strong></p><p dir="ltr" style="text-align:left">Boulevard Rene Branquart 80</p><p dir="ltr" style="text-align:left">7860 Lessines</p><p dir="ltr" style="text-align:left">Belgium</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            	تم آخر اعتماد لهذه النشرة في مارس 2019.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                CERNEVIT, powder for solution for injection or infusion
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each vial of powder contains:

Retinol palmitate 	3500 IU
Cholecalciferol 	220 UI
DL-α-tocopherol	10.20 mg
Ascorbic acid	125 mg
Cocarboxylase tetrahydrate	5.80 mg
Riboflavin dihydrated sodium phosphate	5.67 mg
Pyridoxine hydrochloride	5.50 mg
Cyanocobalamin	6 µg
Folic acid	414 µg
Dexpanthenol	16.15 mg
D-Biotin 	69 µg
Nicotinamide	46 mg

equivalent to:

Vitamin A (Retinol)	3500 IU
Vitamin D3	220 UI
Vitamin E (α tocopherol)	11.20 IU
Vitamin C	125 mg
Vitamin B1 (thiamine)	3.51 mg
Vitamin B2 (riboflavin)	4.14 mg
Vitamin B6 (pyridoxine)	4.53 mg
Vitamin B12	6 µg
Folic acid	414 µg
Pantothenic acid	17.25 mg
Biotin 	69 µg
Vitamin PP (niacin)	46 mg

For a full list of excipients, see section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder for solution for injection or infusion.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Supply of vitamins corresponding to the daily needs of adults and children over 11 years requiring multi-vitamin supplementation by the parenteral route when oral nutrition is contraindicated, impossible or insufficient (e.g. due to malnutrition, gastrointestinal malabsorption, parenteral nutrition, etc).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Dosage</strong></p><p>&nbsp;</p><p>Adults and children aged over 11 years: 1 vial/day.</p><p>&nbsp;</p><p><strong>Administration</strong></p><p><strong>&nbsp;</strong></p><p>Method of Reconstitution: see section 6.6 instructions for use and handling.</p><p>&nbsp;</p><p>Intravenous route: By slow intravenous injection (at least 10 minutes) or infusion in a solution of 5% glucose or 0.9% sodium chloride solution for infusion.</p><p>&nbsp;</p><p>CERNEVIT may be included in the composition of nutritive admixtures combining carbohydrates, lipids, amino acids and electrolytes, provided that compatibility and stability have been previously confirmed for each nutritive admixture used, &nbsp;to meet nutrient needs and prevent deficiencies and complications from developing.</p><p>&nbsp;</p><p>The total vitamin amounts from all sources such as nutritional sources, other vitamin supplements, or medications that contain vitamins as inactive ingredients (see Section 4.5) should be considered.</p><p>&nbsp;</p><p>The patient&rsquo;s clinical status and vitamin levels should be monitored to ensure maintenance of adequate levels.</p><p>&nbsp;</p><p>It should be taken into account that some vitamins, especially A, B2, and B6 are sensitive to ultraviolet light (e.g., direct or indirect sun light). In addition, loss of vitamins A, B1, C, and E may increase with higher levels of oxygen in the solution. These factors should be considered if adequate vitamin levels are not achieved.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                CERNEVIT must not be used in:

-	hypersensitivity to the active constituents, especially vitamin B1 or to any of the excipients listed in section 6.1, including soy protein/products (lecithin in mixed micelle is soy-derived) or peanut protein/products,

-	hypervitaminosis from any vitamin contained in this formulation.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>WARNINGS</p><p><strong>&nbsp;</strong></p><p><u>Hypersensitivity Reactions</u></p><p>&nbsp;</p><ul><li>Severe systemic hypersensitivity reactions have been reported with CERNEVIT, other multivitamin preparations, and individual vitamins (including A, B1, B2, B12 and folic acid). Reactions with fatal outcome have been reported with CERNEVIT and other parenteral vitamin products (See Section 4.8).</li></ul><p>&nbsp;</p><ul><li>Cross-allergic reactions between soybean and peanut proteins have been observed.</li></ul><p>&nbsp;</p><ul><li>In some cases, the manifestations of a hypersensitivity reaction during intravenous administration of multivitamins may be rate related. If infused intravenously, CERNEVIT should be administered slowly. If injected intravenously, the injection must be administered slowly (over at least 10 minutes).</li></ul><p>&nbsp;</p><ul><li>The infusion or injection must be stopped immediately if signs or symptoms of a hypersensitivity reaction develop.</li></ul><p>&nbsp;</p><p><u>Vitamin Toxicity</u></p><p>&nbsp;</p><ul><li>The patient&rsquo;s clinical status and blood vitamin concentrations should be monitored to avoid overdose and toxic effects, especially with vitamins A, D and E, and in particular in patients who receive additional vitamins from other sources or use other agents that increase the risk of vitamin toxicity.</li></ul><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Monitoring is particularly important in patients receiving long-term supplementation.</p><p>&nbsp;</p><p><u>Hypervitaminosis A</u></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The risk for hypervitaminosis A and vitamin A toxicity (e.g., skin and bone abnormalities, diplopia, cirrhosis) is increased in, for example:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; patients with protein malnutrition,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; patients with renal impairment (even in the absence of vitamin A supplementation),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; patients with hepatic impairment,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; patients with small body size (e.g., paediatric patients), and</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; patients on chronic therapy.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute hepatic disease in patients with saturated hepatic vitamin A stores can lead to the manifestation of vitamin A toxicity.</p><p>&nbsp;</p><p><u>Refeeding Syndrome in Patients Receiving Parenteral Nutrition</u></p><p>&nbsp;</p><p>Refeeding severely undernourished patients may result in refeeding syndrome that is characterized by the shift of potassium, phosphorus, and magnesium intracellularly as the patient becomes anabolic. Thiamine deficiency and fluid retention may also develop. Careful monitoring and slowly increasing nutrient intakes while avoiding overfeeding can prevent these complications. Should nutrient deficiencies occur, appropriate supplementation may be warranted.</p><p>&nbsp;</p><p><u>Precipitates in Patients Receiving Parenteral Nutrition</u></p><p>&nbsp;</p><p>Pulmonary vascular precipitates have been reported in patients receiving parenteral nutrition. In some cases, fatal outcomes have occurred. Excessive addition of calcium and phosphate increases the risk of the formation of calcium phosphate precipitates. Precipitates have been reported even in the absence of phosphate salt in the solution. Precipitation distal to the in-line filter and suspected precipitate formation in the blood stream have also been reported.</p><p>&nbsp;</p><p>In addition to inspection of the solution, the infusion set and catheter should also periodically be checked for precipitates.</p><p>&nbsp;</p><p>If signs of pulmonary distress occur, the infusion should be stopped and medical evaluation initiated.</p><p>&nbsp;</p><p><strong>PRECAUTIONS</strong></p><p><strong>&nbsp;</strong></p><p><u>Hepatic Effects </u></p><p><u>&nbsp;</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Monitoring of liver function parameters is recommended in patients receiving CERNEVIT. Particularly close monitoring is recommended in patients with hepatic jaundice or other evidence of cholestasis.</p><p>&nbsp;</p><p>In patients receiving&nbsp;CERNEVIT, instances of liver enzyme increases have been reported, including&nbsp;isolated alanine aminotransferase (ALT) increases in patients with inflammatory&nbsp;bowel disease (see Section 4.8).</p><p>&nbsp;</p><p>In addition, an increase in bile acid levels (total and individual bile acids including glycocholic acid) have been reported in patients receiving CERNEVIT.&nbsp;</p><p>&nbsp;</p><ul><li>Hepatobiliary disorders including cholestasis, hepatic steatosis, fibrosis and cirrhosis, possibly leading to hepatic failure, as well as cholecystitis and cholelithiasis are known to develop in some patients on parenteral nutrition (including vitamin supplemented parenteral nutrition). The etiology of these disorders is thought to be multifactorial and may differ between patients. Patients developing abnormal laboratory parameters or other signs of hepatobiliary disorders should be assessed early by a clinician knowledgeable in liver diseases in order to identify possible causative and contributory factors, and possible therapeutic and prophylactic interventions.</li></ul><p>&nbsp;</p><p><u>Use in Patients with Impaired Hepatic Function</u></p><p>&nbsp;</p><p>Patients with hepatic impairment may need individualized vitamin supplementation, depending on the degree of renal impairment and the presence of concomitant medical conditions. In patients with severe renal impairment, particular attention should be placed on maintaining adequate vitamin D status and preventing vitamin A toxicity, which may develop in such patients with low-dose vitamin A supplementation or even without supplementation.</p><p>&nbsp;</p><p>Pyridoxine (vitamin B6) hypervitaminosis and toxicity (peripheral neuropathy, involuntary movements) have been reported in patients on chronic haemodialysis receiving intravenous multivitamins containing 4 mg pyridoxine administered three times a week.</p><p>&nbsp;</p><p><u>General Monitoring</u></p><p>&nbsp;</p><p>Clinical status and vitamin levels should be monitored in patients receiving parenteral multivitamins as the only source of vitamins for extended periods of time. It is particularly important to monitor for adequate supplementation of, for example:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vitamin A in patients with pressure ulcers, wounds, burns, short bowel&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; syndrome or cystic fibrosis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vitamin B1 in dialysis patients</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vitamin B2 in cancer patients</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vitamin B6 in patients with renal impairment</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Individual vitamins whose requirements may be increased due to interactions with other medicines (see Section 4.5).</p><p>Deficiency of one or more vitamins must be corrected by specific supplementation.</p><p>&nbsp;</p><p><u>Vitamin K</u></p><p>&nbsp;</p><p>CERNEVIT does not contain vitamin K, which should be administered separately if necessary.</p><p>&nbsp;</p><p><u>Use in Patients with Vitamin B12 Deficiency</u></p><p>&nbsp;</p><p>Evaluation of vitamin B12 status is recommended before starting supplementation with CERNEVIT in patients at risk for vitamin B12 deficiency and/or when supplementation with CERNEVIT over several weeks is planned.</p><p>&nbsp;</p><p>After several days of administration, both the individual amounts of cyanocobalamin (vitamin B12) and folic acid in CERNEVIT may be sufficient to result in an increase in red blood cell count, reticulocyte count, and hemoglobin values in some patients with vitamin B12 deficiency-associated megaloblastic anemia. This may be masking an existing vitamin B12 deficiency. Effective treatment of vitamin B12 deficiency requires higher doses of cyanocobalamin than provided in CERNEVIT.</p><p>&nbsp;</p><p>Folic acid supplementation in patients with vitamin B12 deficiency, who do not also receive vitamin B12, does not prevent the development or progression of neurologic manifestations associated with the vitamin B12 deficiency. It has been suggested that neurologic deterioration may even be accelerated.</p><p>&nbsp;</p><p>When interpreting levels of vitamin B12, it should be taken into account that recent intake of vitamin B12 may result in normal levels despite a tissue deficiency.</p><p>&nbsp;</p><p><u>Laboratory Test Interferences</u></p><p>&nbsp;</p><p><u>Biotin</u></p><p>&nbsp;</p><p>Biotin may interfere with laboratory tests that are based on a biotin/streptavidin interaction, leading to either falsely decreased or falsely increased test results, depending on the assay. The risk of interference is higher in children and patients with renal impairment and increases with higher doses. When interpreting results of laboratory tests, possible biotin interference has to be taken into consideration, especially if a lack of coherence with the clinical presentation is observed (e.g. thyroid test results mimicking Graves&rsquo; disease in asymptomatic patients taking biotin or false negative troponin test results in patients with myocardial infarction taking biotin). Alternative tests not susceptible to biotin interference should be used, if available, in cases where interference is suspected. The laboratory personnel should be consulted when ordering laboratory tests in patients taking biotin.</p><p>&nbsp;</p><p><u>Ascorbic acid </u></p><p>&nbsp;</p><p>Depending on the reagents used, the presence of ascorbic acid in blood and urine may cause false high or low glucose readings in some urine and blood glucose testing systems, including test strips and handheld glucose meters. The technical information for any laboratory test should be consulted to determine the potential interference from vitamins.</p><p>&nbsp;</p><p><u>Sodium Content </u></p><p>&nbsp;</p><p>CERNEVIT contains 24 mg sodium (1 mmoL) per vial. This should be taken into consideration if patients are on a controlled sodium diet.</p><p>&nbsp;</p><p><u>Pediatric Use</u></p><p>&nbsp;</p><p>CERNEVIT is indicated in pediatric patients over 11 years of age (see also Section 4.4: Hypervitaminosis A above).</p><p>&nbsp;</p><p><u>Geriatric Use</u></p><p>&nbsp;</p><p>In general, dosage adjustments for an elderly patient should be considered (reducing the dose and/or extending the dosing intervals) reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or drug therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Interactions between specific vitamins in CERNEVIT and other agents should be managed accordingly.</p><p>&nbsp;</p><p>Such interactions include:</p><p>&nbsp;</p><ul><li>Agents that can cause pseudotumor cerebri (including certain tetracyclines): Increased risk for pseudotumor cerebri by concomitant administration of Vitamin A.</li></ul><p>&nbsp;</p><ul><li>Alcohol (chronic excessive consumption): Increases the risk of vitamin A hepatotoxicity.</li></ul><p>&nbsp;</p><ul><li>Anticonvulsants (phenytoin, fosphenytoin, phenobarbital, primidone): Folic acid supplementation can decrease the anticonvulsant serum concentration and increase seizure risk.</li></ul><p><strong>&nbsp;</strong></p><ul><li>Antiplatelet agents (e.g., aspirin): Vitamin E can add to the inhibition of platelet function.</li></ul><p>&nbsp;</p><ul><li>Aspirin (high dose therapy): Can reduce folic acid levels by increasing urinary excretion.</li></ul><p>&nbsp;</p><ul><li>Certain anticonvulsants (e.g., phenytoin, carbamazepine, phenobarbital, valproate): Can cause folate, pyridoxine and vitamin D deficiencies.</li></ul><p>&nbsp;</p><ul><li>Certain antiretroviral agents: Decreased vitamin D levels have been associated with, e.g., efavirenz and zidovudine. Decreased formation of the active vitamin D metabolite has been associated with protease inhibitors.</li></ul><p>&nbsp;</p><ul><li>Chloramphenicol: Can inhibit the hematological response to vitamin B12 therapy.</li></ul><p>&nbsp;</p><ul><li>Deferoxamine: Increased risk of iron-induced cardiac failure due to increased iron mobilization by supraphysiologic vitamin C supplementation. For specific precautions, refer to deferoxamine product information.</li></ul><p>&nbsp;</p><ul><li>Ethionamide: Can cause pyridoxine deficiency.</li></ul><p>&nbsp;</p><ul><li>Fluoropyrimidines (5-fluorouracil, capecitabine, tegafur): Increased cytotoxicity when combined with folic acid.</li></ul><p>&nbsp;</p><ul><li>Folate antagonists, e.g., methotrexate, sulfasalazine, pyrimethamine, triamterene, trimethoprim, and high doses of tea catechins: Block the conversion of folate to its active metabolites and reduce the effectiveness of supplementation.</li></ul><p>&nbsp;</p><ul><li>Folate antimetabolites (methotrexate, raltitrexed): Folic acid supplementation can decrease the antimetabolite effects.</li></ul><p>&nbsp;</p><ul><li>Levodopa: Vitamin B6 may reduce the effectiveness of levodopa as the decarboxylation of levodopa requires a vitamin B6 dependent enzyme. A dopa-decarboxylase inhibitor such as carbidopa can be added to prevent this interaction.</li></ul><p>&nbsp;</p><ul><li>Pyridoxine antagonists, including cycloserine, hydralazine, isoniazid, penicillamine, phenelzine: Can cause pyridoxine deficiency.</li></ul><p>&nbsp;</p><ul><li>Retinoids, including bexarotene: Increase the risk of toxicity when used concomitantly with vitamin A (see Section 4.4: Hypervitaminosis A).</li></ul><p>&nbsp;</p><ul><li>Theophylline: Can cause pyridoxine deficiency.</li></ul><p>&nbsp;</p><ul><li>Tipranavir oral solution: Contains 116 IU/mL of vitamin E, which is in excess of the daily recommended intake.</li></ul><p>&nbsp;</p><ul><li>Vitamin K antagonists (e.g., warfarin): Enhanced anticoagulant effect by vitamin E.</li></ul><p>&nbsp;</p><p><u>Drugs that Bind to alpha1-Acid Glycoprotein (AAG):</u></p><p>&nbsp;</p><p>In an in vitro study using human serum, concentrations of glycocholic acid approximately 4 times higher than the glycocholic acid serum concentration that would result from a bolus injection of CERNEVIT in adults, increased the unbound fraction of selected drugs known to bind to alpha1-acid glycoprotein (AAG) by 50-80%.</p><p>&nbsp;</p><p>It is not known whether this effect is clinically relevant if the amount of glycocholic acid contained in a standard CERNEVIT dose (as a component of the mixed micelles) is administered by slow intravenous injection, intramuscular injection, or infused over a longer period of time.</p><p>&nbsp;</p><p>Patients receiving CERNEVIT as well as drugs that bind to AAG should be closely monitored for increases in response of these drugs. These include propranolol, prazosin, and numerous others.</p><p>&nbsp;</p><p><u>Interactions with Additional Vitamin Supplementation:</u></p><p>&nbsp;</p><p>Some medications can interact with certain vitamins at doses markedly higher than those provided with CERNEVIT. This should be taken into consideration in patients receiving vitamins from multiple sources, and when applicable, patients should be monitored for such interactions and managed accordingly.</p><p>&nbsp;</p><p>Such interactions include:</p><p>&nbsp;</p><ul><li>Amiodarone: Concomitant use of vitamin B6 can enhance amiodaroneinduced photosensitivity.</li></ul><p>&nbsp;</p><ul><li>Agents with anticoagulant effects (e.g., such as abciximab, clopidogrel, heparin, warfarin): Increased bleeding risk due to additional risk of bleeding associated with high vitamin A doses</li><li>Carbamazepine: Inhibition of metabolism associated with large nicotinamide doses.</li></ul><p>&nbsp;</p><ul><li>Chemotherapeutic agents that rely on the production of reactive oxygen species for their activity: Possible inhibition of chemotherapy activity by the antioxidant effects of high doses of vitamin E.</li></ul><p>&nbsp;</p><ul><li>Insulin, antidiabetic agents: Decreased insulin sensitivity associated with large nicotinamide doses.</li></ul><p>&nbsp;</p><ul><li>Iron: High dose-supplementation with vitamin E may reduce the haematological response to iron in anaemic patients.</li></ul><p>&nbsp;</p><ul><li>Oral contraceptives (combination hormone types): High doses of vitamin C have been associated with breakthrough bleeding and contraceptive failure.</li></ul><p>&nbsp;</p><ul><li>Phenobarbital: Increased metabolism/lower serum levels and reduced effect associated with large pyridoxine doses.</li></ul><p>&nbsp;</p><ul><li>Phenytoin, fosphenytoin: Lower serum levels associated with large pyridoxine doses.</li></ul><p>&nbsp;</p><ul><li>Primidone: Decreased metabolism to phenobarbital and increased primidone levels associated with large nicotinamide doses</li></ul><p>&nbsp;</p><p><u>Pernicious anaemia</u></p><p>&nbsp;</p><p>The folic acid in CERNEVIT may obscure pernicious anaemia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Physicians should carefully consider the potential risks and benefits for each specific patient before prescribing CERNEVIT.</p><p>&nbsp;</p><p><strong>Pregnancy</strong></p><p>No safety data are available for CERNEVIT administered during pregnancy or in breastfeeding women. This medicinal product may be prescribed during pregnancy if required, providing the indication and dosages are observed in order to avoid vitamin overdose.</p><p>&nbsp;</p><p><strong>Lactation</strong></p><p>Use is not recommended during breastfeeding because of the risk of vitamin A overdose in the neonate.</p><p>&nbsp;</p><p><strong>Fertility</strong></p><p>There are no adequate data from the use of CERNEVIT with regards to fertility in male or female patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no information on the effects of CERNEVIT on the ability to operate an automobile or other heavy machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse drug reactions (ADRs) that occurred after administration of CERNEVIT are presented with their relative frequencies; these include ADRs documented in clinical trials and those from post-marketing reports. CERNEVIT was administered during 3 clinical trials to 267 adult patients requiring a parenteral vitamin supplement.&nbsp;</p><p>&nbsp;</p><p>Frequencies of ARs are reported, using the following convention: very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1000 to &lt;1/100); rare (&ge;1/10000 to &lt;1/1000); very rare (&lt;1/10000); and unknown (cannot be estimated from the available data).</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Clinical Trial and Post-Marketing Adverse Drug Reactions Reported for CERNEVIT:System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Preferred MedDRA Term</strong></p></td><td style="vertical-align:top"><p>Frequency<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Systemic hypersensitivity reactions with manifestations such as respiratory distress, chest discomfort,&nbsp; throat tightness, urticaria, rash, erythema, epigastric discomfort, as well as cardiac arrest with fatal outcome</p></td><td style="vertical-align:top"><p>Unknown</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top"><p>Vitamin A increased2<sup>, 3 </sup></p><p>Retinol binding protein increased</p></td><td style="vertical-align:top"><p>Unknown</p><p>Unknown</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Dysgeusia (metallic taste)</p></td><td style="vertical-align:top"><p>Unknown</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>Tachycardia</p></td><td style="vertical-align:top"><p>Unknown</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Tachypnea</p></td><td style="vertical-align:top"><p>Unknown</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Nausea</p><p>Vomiting</p><p>Diarrhea</p></td><td style="vertical-align:top"><p>Uncommon</p><p>Uncommon</p><p>Unknown</p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>Transaminases increased</p><p>Isolated alanine aminotransferase increased4</p><p>Glutamate dehydrogenase increased</p><p>Blood alkaline phosphatase increased</p><p>Bile acids increased5</p><p>Gamma-glutamyltransferase increased</p></td><td style="vertical-align:top"><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Pruritus</p></td><td style="vertical-align:top"><p>Unknown</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Injection/Infusion Site Pain</p><p>Pyrexia</p><p>Generalized aching</p><p>Infusion site reactions, i.e., burning sensation, rash</p></td><td style="vertical-align:top"><p>Common</p><p>Unknown</p><p>Unknown</p><p>Unknown</p></td></tr></tbody></table><p>&nbsp;</p><p><sup>1</sup> The frequency either cannot be determined or the overall number of patients in the individual studies is too small to permit a valid estimation of frequency.</p><p>&nbsp;</p><p><sup>2 </sup>No symptoms of hypervitaminosis A were reported</p><p>&nbsp;</p><p><sup>3</sup> Elevated plasma vitamin A levels have been reported in 8 of 20 patients receiving CERNEVIT in parenteral nutrition at day 45 of administration. From day 45 to day 90 of product administration the high values of vitamin A remained stable (maximum observed value of 3.6 &micro;mol/L at day 90; normal values: 1 to 2.6 &micro;mol/L). In addition, an average increase in retinol binding protein (RBP) was also identified. A maximum observed RBP value of 60 mg/L at day 90 (normal values: 30 to 50 mg/L), was reported.</p><p>&nbsp;</p><p><sup>4 </sup>Isolated alanine aminotransferase increases was reported in the presence of inflammatory bowel disease. CERNEVIT was administered by intravenous injection in the absence of parenteral nutrition.</p><p>&nbsp;</p><p><sup>5 </sup>An increase in total and individual bile acids including glycocholic acid has been reported to develop early in the course of parenteral nutrition administration in patients receiving CERNEVIT.</p><p><u>&nbsp;</u></p><p><u>&nbsp;</u></p><p><u>Reporting of suspected adverse reactions</u></p><p>&nbsp;</p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the below national reporting system.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p>&nbsp;</p><ul><li><strong>Saudi Arabia:</strong></li></ul><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:604px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>- SFDA Call Center: 19999</p><p>- E-mail: npc.drug@sfda.gov.sa</p><p>- Website: https://ade.sfda.gov.sa/ <u>&nbsp;</u>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:604px"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acute or chronic overdose of vitamins (in particular A, B6, D, and E) can cause symptomatic hypervitaminosis.</p><p>&nbsp;</p><p>The risk of overdose is particularly high if a patient receives vitamins from multiple sources and overall supplementation of a vitamin does not match the patient&rsquo;s individual requirements, and in patients with increased susceptibility to hypervitaminosis (see Section 4.4).</p><p>&nbsp;</p><p>The signs of overdose of CERNEVIT are mostly those resulting from administration of excessive doses of vitamin A.</p><p>&nbsp;</p><p>Treatment of vitamin overdose usually consists of withdrawal of the vitamin and other measures as clinically indicated.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Balanced association of all water soluble and fat soluble, vitamins essential for the metabolism of the adult and the child aged over 11 years, with the exception of Vitamin K.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glycine</p><p>Glycocholic acid</p><p>Soyabean phosphatides</p><p>Sodium hydroxide</p><p>Hydrochloric acid, Concentrated</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</li></ul><ul><li>Additives may be incompatible with parenteral nutrition containing CERNEVIT.</li></ul><ul><li>If co-administration of drugs that are incompatible at the Y-site is necessary, administer via separate IV lines.</li></ul><ul><li>Vitamin A and thiamine in CERNEVIT may react with bisulfites in parenteral nutrition solutions (e.g., as a result of admixtures) leading to degradation of vitamin A and thiamine.</li></ul><ul><li>An increase in pH of a solution may increase the degradation of some vitamins. This should be considered when adding alkaline solutions to the admixture containing CERNEVIT.</li></ul><ul><li>Folic acid stability can be impaired with increased calcium concentrations in an admixture.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened: 24 months.

Chemical and Physical in-use stability has been demonstrated for CERNEVIT for 24 hours when reconstituted with 5ml of Water for Injections and stored under refrigeration. From a microbiological point of view, the product should be used immediately. If not used immediately, in use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8°C, unless reconstitution/dilution etc has taken place in controlled and validated aseptic conditions.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25&deg;C.</p><p>Keep the vial in the outer carton.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Type I Ph.Eur. brown glass vial with an elastomer stopper, containing an orange-yellow sterile cake of powder.</p><p>Box of 1, 10 or 20 vials of lyophilised powder</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aseptic conditions must be followed during reconstitution and when used as part of an admixture in parenteral nutrition.</p><p>Using a syringe, inject 5 ml of water for injections or 5% glucose solution or 0,9% sodium chloride solution into the vial. The obtained solution is yellow-orange in colour.</p><p>Mix gently to dissolve the lyophilized powder.</p><p>Before transfer from the vial, CERNEVIT must be completely dissolved.</p><p>Do not use product unless the reconstituted solution is clear, and the original seal is intact and the container is undamaged.</p><p>After addition of CERNEVIT to a parenteral nutrition solution, check for any abnormal color change and/or the appearance of precipitates, insoluble complexes or crystals.</p><p>Mix the final solution thoroughly when CERNEVIT is used as an admixture in parenteral nutrition.</p><p>Single use only. Any unused portion of reconstituted CERNEVIT should be discarded and should not be stored for subsequent admixing.</p><p>Use of a final filter is recommended during administration of all parenteral nutrition solutions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter S.A.
Boulevard Rene Branquart 80
7860 Lessines
Belgium
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                May 14, 2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>